Breaking Down FDA's Breakthrough Program – Infographic
Executive Summary
A review of the impact FDA's newest expedited approval pathway has had on drug development and regulatory review, using data from Pink Sheet's FDA Performance Tracker, BioMedTracker and MedTrack.